Hortensia De la Corte-Rodriguez 1 , E Carlos Rodriguez-Merchan 2 , M Teresa Alvarez-Roman 3 , Monica Martin-Salces 3 , Victor Jimenez-Yuste 3 Show Affiliations »
Abstract
BACKGROUND: It is important to discard those practices that do not add value. As a result, several initiatives have emerged. All of them try to improve patient safety and the use of health resources. PURPOSE: To present a compendium of "do not do recommendations" in the context of hemophilia. METHODS: A review of the literature and current clinical guidelines has been made, based on the best evidence available to date. RESULTS: The following 13 recommendations stand out: 1) Do not delay the administration of factor after trauma; 2) do not use fresh frozen plasma or cryoprecipitate; 3) do not use desmopressin in case of hematuria; 4) do not change the product in the first 50 prophylaxis exposures; 5) do not interrupt immunotolerance; 6) do not administer aspirin or NSAIDs; 7) do not administer intramuscular injections; 8) do not do routine radiographs of the joint in case of acute hemarthrosis; 9) Do not apply closed casts for fractures; 10) do not discourage the performance of physical activities; 11) do not deny surgery to a patient with an inhibitor; 12) do not perform instrumental deliveries in fetuses with hemophilia; 13) do not use factor IX (FIX) in patients with hemophilia B with inhibitor and a history of anaphylaxis after administration of FIX. CONCLUSION: The information mentioned previously can be useful in the management of hemophilia, from different levels of care. As far as we know, this is the first initiative of this type regarding hemophilia. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
BACKGROUND: It is important to discard those practices that do not add value. As a result, several initiatives have emerged. All of them try to improve patient safety and the use of health resources. PURPOSE: To present a compendium of "do not do recommendations" in the context of hemophilia . METHODS: A review of the literature and current clinical guidelines has been made, based on the best evidence available to date. RESULTS: The following 13 recommendations stand out: 1) Do not delay the administration of factor after trauma ; 2) do not use fresh frozen plasma or cryoprecipitate; 3) do not use desmopressin in case of hematuria ; 4) do not change the product in the first 50 prophylaxis exposures; 5) do not interrupt immunotolerance; 6) do not administer aspirin or NSAIDs; 7) do not administer intramuscular injections; 8) do not do routine radiographs of the joint in case of acute hemarthrosis ; 9) Do not apply closed casts for fractures ; 10) do not discourage the performance of physical activities; 11) do not deny surgery to a patient with an inhibitor; 12) do not perform instrumental deliveries in fetuses with hemophilia ; 13) do not use factor IX (FIX) in patients with hemophilia B with inhibitor and a history of anaphylaxis after administration of FIX. CONCLUSION: The information mentioned previously can be useful in the management of hemophilia , from different levels of care. As far as we know, this is the first initiative of this type regarding hemophilia . Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Entities: Disease
Gene
Species
Keywords:
Hemophilia; clinical guidelines; do not do; health resources; patient safety; recommendations
Mesh： See more »
Substances： See more »
Year: 2020
PMID： 32133968 DOI： 10.2174/1871529X20666200305111323
Source DB: PubMed Journal: Cardiovasc Hematol Disord Drug Targets ISSN： 1871-529X